MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BGM — BGM Group Ltd. Class A Ordinary Shares
NasdaqBGM Group Ltd. Class A Ordinary Shares
$9.34
+1.52(+19.44%)
- O
- 7.70
- H
- 9.91
- L
- 7.70
- V
- 38.33K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About BGM
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
IndustryCommon Stock
SectorNot available
IPO DateJan 12, 2021
Employees471
Stock ExchangeNasdaq
Ticker SymbolBGM
Websitehttps://www.bgmgroupltd.com
Key Financial Statistics
| Market Cap | $96.15M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.23 - $10.80 |
| 52-Week Avg Volume | 206.8K |
| VWAP | $8.82 |
| Transactions | 5,862 |
| Total Recorded Bars | 1,438 days |